TheStreet's founder Jim Cramer hosted this month's Trading Strategies session and he, along with his expert panel, tackled everything from the risk of recession to bitcoin.

His panel included:

  • Tony Dwyer, senior managing director and chief market strategist for Canaccord Genuity;
  • Stephen "Sarge" Guilfoyle, co-manager of TheStreet's Stocks Under $10 model portfolio and author of TheStreet's Market Recon morning newsletter;
  • Brian Levitt, senior investment strategist for OppenheimerFunds;
  • Jeff Marks, senior portfolio analyst for Action Alerts Plus, Jim Cramer's charitable trust and club for investors

In this clip, they disciss healthcare and who's invested in it.

Guilfoyle actually admits his is "not smart enough" to invest in the space because it is so unpredictable and is worried that about pharma stocks, in general, because he believes they are the "target of both political parties."

Dwyer, too, believes the whole sector is just "hard to figure it out."

Marks does think there's opportunity in the medical device stocks and likes Abbot Labs (ABT - Get Report) , which is a in Cramer's Action Alerts Plus portfolio.

Listen in to hear their conversation and learn about all of it.

Be sure to catch all of our March Trading Strategies articles, videos and podcasts here.

Catch the Instant Replay , sponsored by Charles Schwab.